Most Cited & Viewed

Citations Article
 
Developments and Challenges for mAb-Based Therapeutics
 
Antibody Glycosylation and Inflammation
 
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
 
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
 
Antibody Drug Conjugates as Cancer Therapeutics
 
Antibody Conjugates: From Heterogeneous Populations to Defined Reagents
 
Antibody-Based Immunotoxins for the Treatment of Cancer
 
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
 
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
 
Cell-Free Synthesis Meets Antibody Production: A Review
Views Article
Antibody Glycosylation and Inflammation
Antibody Drug Conjugates as Cancer Therapeutics
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
Developments and Challenges for mAb-Based Therapeutics
Shark Variable New Antigen Receptor (VNAR) Single Domain Antibody Fragments: Stability and Diagnostic Applications
Communication between B-Cells and Microbiota for the Maintenance of Intestinal Homeostasis
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
IgG Antibody 3D Structures and Dynamics
Cell-Free Synthesis Meets Antibody Production: A Review
Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Back to TopTop